IGF::OT::IGF Vascular Interventions/Innovations and Therapeutic Advances(VITA): A Phase 1 Study to Assess the Safety and Pharmacokinetics of GMI-1271 in Healthy Adult Subjects and Calf Vein DVT
IGF::OT::IGF Vascular Interventions/Innovations and Therapeutic Advances(VITA): A Phase 1 Study to Assess the Safety and Pharmacokinetics of GMI-1271 in Healthy Adult Subjects and Calf Vein DVT
IGF::OT::IGF 血管干预/创新和治疗进展 (VITA)：一项评估 GMI-1271 在健康成人受试者和小腿静脉 DVT 中的安全性和药代动力学的 1 期研究
批准号：
8948127
负责人：
COLLEEN VOLGER
金额：
$50.32万
依托单位国家：
美国
项目类别：
财政年份：
2013
资助国家：
美国
项目状态：
已结题
起止时间：
2013-11-15 至 2014-11-14
关键词：
AccountingAdultAdverse effectsBlood VesselsCase StudyCessation of lifeClinicalClinical ResearchContractsDeep Vein ThrombosisDevelopmentDiagnosticDiseaseDrug KineticsFundingGoalsHemorrhageInterventionMedicalModalityNational Heart, Lung, and Blood InstitutePhasePulmonary EmbolismPulmonary HypertensionSafetyStagingSupport ContractsTherapeuticThromboembolismVascular DiseasesVeinsVenousinnovationmortalitynovelphase 1 studyproduct developmentprograms
中文摘要
翻译
血管干预/创新和治疗进展(VITA)计划是美国国家心肺血液研究所(NHLBI)的一项新的翻译计划，旨在支持和加速开发有前景的诊断和治疗模式，以满足未得到满足和服务不足的医疗需求。VITA计划为血管疾病、血栓性疾病和肺动脉高压领域的候选产品的早期翻译开发提供合同支持。
英文摘要
The Vascular Interventions/Innovations and Therapeutic Advances (VITA) Program is a new translational initiative of the National Heart, Lung, and Blood Institute (NHLBI) that enables and accelerates the development of promising diagnostic and therapeutic modalities for unmet and underserved medical needs. The VITA Program provides contract support for early-stage translational development of product candidates in the fields of vascular disorders, thrombotic diseases, and pulmonary hypertension.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
IGF::OT::IGF Vascular Interventions/Innovations and Therapeutic Advances(VITA): A Phase 1 Study to Assess the Safety and Pharmacokinetics of GMI-1271 in Healthy Adult Subjects and Calf Vein DVT
-
批准号：9004521
-
项目类别：
-
资助金额：$59.04万
-
财政年份：2013
-
负责人：COLLEEN VOLGER
-
依托单位：
海外基金
